A Case of rule-out Autoimmune Hepatitis Using Injinoryung-san gagam

인진오령산가감이 유효했던 자가면역성 간염의증 환자 1례

  • Lee, Yu Jin (Dept. of Clinical Korean Medicine, Graduate school, Kyung-Hee University) ;
  • Kim, Soo-hyun (Dept. of Clinical Korean Medicine, Graduate school, Kyung-Hee University) ;
  • Yang, Jung Yun (Dept. of Clinical Korean Medicine, Graduate school, Kyung-Hee University) ;
  • Cho, Ki-Ho (Dept. of Cardiology and Neurology, College of Korean medicine, Kyung-Hee University) ;
  • Moon, Sang-Kwan (Dept. of Cardiology and Neurology, College of Korean medicine, Kyung-Hee University) ;
  • Jung, Woo-Sang (Dept. of Cardiology and Neurology, College of Korean medicine, Kyung-Hee University) ;
  • Kwon, Seungwon (Dept. of Cardiology and Neurology, College of Korean medicine, Kyung-Hee University) ;
  • Jin, Chul (Dept. of Cardiology and Neurology, College of Korean medicine, Kyung-Hee University)
  • 이유진 (경희대학교 대학원 임상한의학과) ;
  • 김수현 (경희대학교 대학원 임상한의학과) ;
  • 양정윤 (경희대학교 대학원 임상한의학과) ;
  • 조기호 (경희대학교 한의과대학 순환신경내과학교실) ;
  • 문상관 (경희대학교 한의과대학 순환신경내과학교실) ;
  • 정우상 (경희대학교 한의과대학 순환신경내과학교실) ;
  • 권승원 (경희대학교 한의과대학 순환신경내과학교실) ;
  • 진철 (경희대학교 한의과대학 순환신경내과학교실)
  • Published : 2019.12.15

Abstract

■ Objectives In this case report, we address a case of a 83-year-old female patient diagnosed with suspicious autoimmune hepatitis. ■ Methods A patient was treated with herbal medication, Injinoryung-san gagam. We evaluated the improvements of symptoms by AST, ALT, GGT, ALP and total score of Fatigue Severity Scale(FSS). ■ Results After 4 weeks of taking Injinoryung-san gagam, there were decrease in abnormal liver enzyme levels with improvement of the patient's fatigue. ■ Conclusion This study suggested that Injinoryung-san gagam might be effective in autoimmune hepatitis patient's liver enzyme levels and fatigue recovery.

Keywords

References

  1. McFarlane IG. Autoimmune hepatitis: diagnostic criteria, subclassifications, and clinical features. Clin Liver Dis 2002;6:605-21 https://doi.org/10.1016/S1089-3261(02)00019-3
  2. Czaja AJ, Santos RM, Porto A, et al. Immune phenotype of chronic liver disease. Dig Dis Sci 1998;43:2149-55. https://doi.org/10.1023/A:1018836004279
  3. Gregorio GV, Portmann B, Reid F, et al. Autoimmune hepatitis in childhood: a 20-year experience. Hepatology 1997;25:541-47. https://doi.org/10.1002/hep.510250308
  4. Czaja AJ. Auto-immune chronic active hepatitis: a specific entity? the negative argument. J Gastroenterol Hepatol. 1990;5:343-51. https://doi.org/10.1111/j.1440-1746.1990.tb01636.x
  5. 추홍민, 신혜령, 문연주 등. 인진오령산 투여가 상승된 간화학 수치에 미치는 영향:후향적 차트 리뷰. 대한한방내과학회지. 2019;40(3):478-90 https://doi.org/10.22246/jikm.2019.40.3.478
  6. Vergani D., Mieli-Vergani G. Autoimmune Hepatitis: Diagnostic Criteria and Serological Testing. Clinical Liver Disease. 2014;3(2):38-41 https://doi.org/10.1002/cld.321
  7. Alvarez F, Berg PA, Bianchi FB, et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999;31:929-38. https://doi.org/10.1016/S0168-8278(99)80297-9
  8. Hennes EM, Zeniya M, Czaja AJ, et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology 2008;48:169-76. https://doi.org/10.1002/hep.22322
  9. Chung KI, Song CH. Clinical Usefulness of Fatigue Severity Scale for Patients with Fatigue, and Anxiety or Depression. Korean J Psychosomatic Medicine. 2001;9(2):164-73.
  10. Michael PM, Albert JC, James DG, et al. Diagnosis and Management of Autoimmune Hepatitis. Hepatology. 2010;51:1-31 https://doi.org/10.1002/hep.23235
  11. Huscher D, Thiele K, Gromnica-Ihle E, et al. Dose-related patterns of glucocorticoid-induced side effects. Annals of the Rheumatic Diseases. 2009;68(7):1119-24. https://doi.org/10.1136/ard.2008.092163
  12. 김하연, 배정한, 최은솔 등. 인진청간탕으로 호전된 스테로이드 부작용을 동반한 자가면역성 간염-원발성 담즙성 간경변증 중복증후군 1례. 대한한방내과학회지 2016;37(3):560-67.
  13. 양주노, 심범상, 최승훈 등. 한양방결합요법에 의한 자가면역성 만성 활동성 간염, 고빌리루빈혈증 1례 보고. 대한암한의학회지 2005;10(1):99-106
  14. 정우상, 박정미. 만성 활동성 B형 간염에서 生肝健脾湯으로 혈청 aminotransferase 수치가 저하된 1례. 대한한방내과학회지. 2000;21(2):337-39
  15. 권정연, 김영지, 박장경 등. Atorvastatin이 주요 원인으로 추정되는 간 기능 장애에 대한 생간건비탕 가미방 치험 1례. 대한한방내과학회지. 2017;38(5):548-54 https://doi.org/10.22246/jikm.2017.38.5.548
  16. 최홍식, 정태영. 생간건비탕을 이용한 급성 약인성 간손상 치험 1례. 대한한방내과학회지. 2004;25(4):207-11
  17. 백종우, 하유군, 박종형 등. 뇌경색 양방치료중 동반된 약인성 간손상의 생간건비탕 치험1례. 경원한의학연구소논문집. 2009;13(1):21-32
  18. 서영호, 김종대, 최해윤 등. 생간건비탕 및 공진단을 병용 투여한 알콜성 간염 추정환자 치험 1례. 2011;36(4):83-9
  19. 심정섭, 김경수, 강대근 등. 간경화환자에서 발생한 간궐증을 생간건비탕으로 치료한 례. 대한한방내과학회지. 2002;23(4):695-701
  20. 박수완, 김대준, 곽민아 등. 황달, 복수, 부종을 주소로 하는 간암 환자에 인진오령산가미 투여로 호전된 1례. 제한동의학술원논문집. 2014;12(1):17-26
  21. 김병운, 김정제. 생간건비탕이 간장의 대사와 재생기능에 미치는 영향. 경희한의대논문집. 1982;5:19-40
  22. 김재용, 김영철, 이장훈 등. 생간건비탕이 HepG2 cell의 증식, 세포사멸 및 활성조절 신 호전달계에 미치는 영향. 대한한방내과학회지. 2006;27(1):149-65
  23. Jang EY, Kim BJ, Lee KT, et al A Survey of Therapeutic Effects of Artemisia capillaris in Liver Diseases. Evidence-based Complementary and Alternative Medicine. 2015:1-10
  24. Han KH, Jeon YJ, Athukorala Y, et al A water extract of Artemisia capillaris prevents 2,2'-azobis(2-amidinopropane) dihydrochloride-induced liver damage in rats. J Med Food. 2006;9(3):342-7. https://doi.org/10.1089/jmf.2006.9.342
  25. Bi X, Wang P, Ma Q, et al Anti-Inflammatory Activities and Liver Protection of Alisol F and 25-Anhydroalisol F through the Inhibition of MAPK, STAT3, and NF-κB Activation In Vitro and In Vivo. Molecules. 2017;8;22(6)